Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Clinical trial NCT01436968 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01436968
- Sponsor
- Candel Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2024-08-01
- Enrollment
- 711
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.